Helsinn Group
Suzanne Cummins is an experienced Computer Systems Validation Specialist at Helsinn Group since September 2015. Previous roles include Project Manager at Systech International, where project management focused on vision, serialization, and aggregation systems in GMP environments. At Merck from April 2009 to May 2014, Suzanne held multiple positions, including Automation Value Stream Lead, where responsibilities included overseeing automation in the vial value stream and leading teams for product introduction recipes. Prior to Merck, roles at Pfizer involved automation project management and engineering for control system replacements, while experience at Kvaerner included project engineering on various pharmaceutical projects, focusing on validation and system integration. Initial engineering experience began at Thurnall PLC, specialized in design and commissioning of software for laboratory robotics. Suzanne holds an MSc in Advanced Manufacturing Systems & Technology and a BEng in Engineering Science & Industrial Management from the University of Liverpool.
This person is not in any teams
This person is not in any offices
Helsinn Group
1 followers
Welcome to Helsinn’s LinkedIn page. This account shall only be used to share (*) news concerning Helsinn. We would like to emphasize that due to the highly regulated nature of the pharma industry, we cannot engage with you online in any discussions concerning our or other companies’ products and/or services, and/or treatment options. It is best to hold such discussions and to seek guidance privately from your healthcare professional Helsinn is a fully integrated, global biopharma company headquartered in Lugano, Switzerland. It is focused on improving the lives of cancer patients all over the world with a leading position in cancer supportive care and an innovative pipeline of cancer therapeutics. Helsinn is a third-generation family-owned company, that since 1976 has been focused on improving the lives of patients, guided by core values of respect, integrity and quality. It operates a unique licensing business model with integrated drug development and manufacturing capabilities. Helsinn has a commercial presence in 190 countries either directly, with operating subsidiaries in the U.S. and China, or via its long-standing trusted partners. Helsinn also has a fully integrated supply chain and product development through its subsidiary in Ireland, Helsinn Birex Pharmaceuticals Ltd. If you are interested in joining Helsinn or one of our affiliates, please visit helsinn.com. Applications should only be submitted via the appropriate country portal under “Working for Helsinn”. Any other sources of communications are unauthorized, and we discourage candidates from replying to suspect employment offers received through unofficial channels. If you are experiencing problems or have questions, please contact: Switzerland: info-HHC@helsinn.com, U.S.: HTU-HR@helsinn.com, Ireland: info-hbp@helsinn.com. [These emails are NOT an application channel: CVs and sensitive information sent inappropriately to the above emails will NOT be considered or processed, and will be DELETED]